Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario de la Princesa (12)

2024

  1. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

2023

  1. Cognitive impairment and dementia in young onset Parkinson’s disease

    Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812

2021

  1. Impact of SAfinamide on depressive symptoms in parkinson’s disease patients (SADness-PD Study): A multicenter retrospective study

    Brain Sciences, Vol. 11, Núm. 2, pp. 1-11

  2. Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1

    Neurologia, Vol. 36, Núm. 2, pp. 149-158

  3. Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2

    Neurologia, Vol. 36, Núm. 2, pp. 159-168

  4. Predictors of clinically significant quality of life impairment in Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1

2020

  1. Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders

    Revista de Neurologia, Vol. 71, Núm. 11, pp. 407-420

  2. Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

    European Journal of Neurology, Vol. 26, Núm. 11, pp. 1399-1407

  2. Remote Monitoring of Treatment Response in Parkinson's Disease: The Habit of Typing on a Computer

    Movement Disorders, Vol. 34, Núm. 10, pp. 1488-1495

2018

  1. Minimal Clinically Important Difference for UPDRS-III in Daily Practice

    Movement Disorders Clinical Practice

2012

  1. Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain

    Leukemia Research, Vol. 36, Núm. 6, pp. 709-714